Reproductive Choices and Family-building Decision Uncertainty Among Young Women at Familial Risk for Breast Cancer
Abstract Background: A family history of breast cancer may impact reproductive choices and decisions about family-building. This study evaluated family-building considerations, plans, and decisional processes among women with a breast cancer family history, and examined sociodemographic, clinical, and psychosocial factors related to decision uncertainty. Methods: Cross-sectional data from the Breast Cancer Family Registry (BCFR) Young Women’s Study were analyzed. Participants were women (18-45 years old) with a breast cancer family history. They completed questionnaires including a Reproductive Choices module. Bivariate analyses and multiple regression evaluated relationships among study variables. Results: Participants (N=471) were on average 30.3 years old (SD=6.7), predominantly non-Hispanic White (75.1%), and over half were childless (58.6%); nearly half (47.8%) desired future children, 16.6% were unsure, and 35.7% did not. Among those interested/unsure (n=303), most considered natural conception (85.8%); many were unsure about alternative options such as embryo genetic testing, donor gametes, surrogacy, and adoption. Between 43–57% endorsed some degree of decision uncertainty. Perceived knowledge about genetic cancer risk and family-building options appeared low overall. In the final model, greater decision uncertainty was associated with having no history of pregnancy, identifying as Ashkenazi Jewish, endorsing concern about a future child's health, lack of concern about family-building timeline, and lower perceived knowledge about genetic cancer risk and family-building options. Conclusions: Among women with a familial risk for breast cancer, decision uncertainty about family-building options is prevalent and is driven by health-related concerns, knowledge gaps, financial barriers, and values-based considerations. Findings can inform targeted decision support interventions for this population.
Authors
- Jennifer S. Ford (ORCID: https://orcid.org/0000-0001-7373-6949)
- Catherine Benedict (ORCID: https://orcid.org/0000-0001-9622-249X)
- Esther M. John (ORCID: https://orcid.org/0000-0003-3259-8003)
- Irene Louise Andrulis (ORCID: https://orcid.org/0000-0002-4226-6435)
- Sarah Violet Colonna (ORCID: https://orcid.org/0000-0002-9026-6990)
- Mary Beth Terry (ORCID: https://orcid.org/0000-0002-4106-5033)
- Allison W. Kurian (ORCID: https://orcid.org/0000-0002-6175-9470)
- Mary Beryl Daly (ORCID: https://orcid.org/0000-0002-7490-6038)
- Jennifer Barsky Reese (ORCID: https://orcid.org/0000-0001-9341-2407)
- Alexandra M. Davis (ORCID: https://orcid.org/0009-0003-4917-3842)
- Melissa C. Southey
- Jeanine Genkinger
Institutions
- Fox Chase Cancer Center (US)
- City University of New York (US)
- Palo Alto University (US)
- University of Toronto (CA)
- Cancer Council Victoria (AU)
- Lunenfeld-Tanenbaum Research Institute (CA)
- University of Utah (US)
- Columbia University Irving Medical Center (US)
- Sinai Health System (CA)
- Stanford Medicine (US)
- Stanford University (US)
Publication Details
- Journal
- Research Square
- Published
- 2026-10-30
- DOI
- https://doi.org/10.21203/rs.3.rs-10935505/v1
- Primary Topic
- BRCA gene mutations in cancer
- Type
- preprint